RWD129 Cost Effectiveness of Onasemnogene Abeparvovec in Infants with Presymptomatic Spinal Muscular Atrophy in Italy
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2846
https://www.valueinhealthjournal.com/article/S1098-3015(23)05976-4/fulltext
Title :
RWD129 Cost Effectiveness of Onasemnogene Abeparvovec in Infants with Presymptomatic Spinal Muscular Atrophy in Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05976-4&doi=10.1016/j.jval.2023.09.2846
First page :
Section Title :
Open access? :
No
Section Order :
12172